Dr. Hal Gunn demonstrates to patients how to administer QBECO SSI, an investigational new treatment for Crohn’s disease. Qu Biologics develops Site Specific Immunomodulators (SSIs), a novel class of immunotherapies that aim to ‘reboot’ the body’s innate immune system.